Pharma company Johnson & Johnson has temporarily halted its coronavirus vaccine trial following an ‘unexplained’ illness in a trial participant.
The Phase 3 trial aims to enroll up to 60,000 people across 200 sites worldwide.
Johnson & Johnson is the fourth pharma company in the US to conduct a Phase 3 trial for a possible coronavirus vaccine.
Tell us your thoughts in the Facebook post and share this with your friends.